Zenlabs Ethica Ltd.

View in App
40.99 ▼0%

24 April 2024, 04:01:00 PM

Company Profile

View details >>
Sector Trading Sector Icon Trading Compare with Sector peers
Industry Trading Industry Icon Trading Compare with Industry peers
Website http://www.zenlabsethica.com
Market Cap 26.68 Cr.
Enterprise Value(EV) 30.68 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.19 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 64.41 Trailing Twelve Months Ending 2023-12
Book Value / Share 15.31 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.68 Calculated using Price: 40.99
Dividend Yield 0.61 Period Ending 2023-03
No. of Shares Subscribed 0.65 Cr. 6,510,015 Shares
FaceValue 10
About Zenlabs Ethica Ltd.
Zenlabs Ethica is one of the leading marketing companies and in collaboration with Zenlabs Pharmaceutical Inc, Canada, the company develops and markets a wide range of quality, affordable and branded drugs.

Zenlabs Ethica Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Zenlabs Ethica Ltd. Performance

View details >>
1 Day
1 Week
-0.02%
1 Month
-0.05%
3 Month
-25.88%
6 Month
+13.86%
1 Year
-23.71%
2 Year
+28.70%
5 Year
-23.67%
10 Year
+474.09%

Zenlabs Ethica Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -3.31 5.04 17.99 18.18 16.53 -11.05 9.61 8.74 5.14
Return on Capital Employed (%) -3 2.9 21.03 23.85 23.44 -11.27 13.77 16.21 10.34
Return on Assets (%) -1.76 1 2.99 3.69 3.91 -2.53 2.35 2.25 1.21

Zenlabs Ethica Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2 5 6 7 8 7 9 9 10 10
Non Curr. Liab. 0 1 1 0 1 0 2 3 4 3
Curr. Liab. 2 25 27 22 26 26 21 25 29 26
Minority Int.
Equity & Liab. 4 30 33 30 35 34 32 38 43 39
Non Curr. Assets 3 3 3 2 2 2 4 4 6 5
Curr. Assets 1 27 31 28 33 32 27 33 38 34
Misc. Exp. not W/O
Total Assets 4 30 33 30 35 34 32 38 43 39

Zenlabs Ethica Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 16 81 72 67 60 57 69 67 58
Other Income 0 0 0 0 0 0 0 0 0
Total Income 16 81 72 67 60 57 69 67 58
Total Expenditure 0 -16 -80 -70 -65 -61 -55 -67 -64 -56
PBIDT 0 0 2 2 2 -1 2 2 3 2
Interest 0 0 0 0 0 0 0 -1 -1
Depreciation 0 0 0 0 0 0 -1 -1 -1 -1
Taxation 0 0 0 0 -1 0 0 0 0 0
Exceptional Items 0 -1 -1
PAT 0 0 1 1 1 -1 1 1 0 0
Adjusted EPS 0 0 1 2 2 -1 1 1 1 0

Zenlabs Ethica Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 -1 0 1 0 -8 0 2
Cash Fr. Inv. -2 0 0 0 0 0 -1
Cash Fr. Finan. 3 0 0 0 0 -1 0 0
Net Change 0 0 2 -1 0 0 0 -9 0 0
Cash & Cash Eqvt 0 2 1 1 2 2 2 2 2

Zenlabs Ethica Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 67.61 63.29 60.51 59.12 59.12 59.12 59.12 59.12 52.98
Public 32.39 36.71 39.49 40.88 40.88 40.88 40.88 40.88 47.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Zenlabs Ethica Ltd. Announcements

View details >>
Mon, 22 Apr 2024
Announcement under Regulation 30 (LODR)-Demise
Intimation of Sad Demises of Mr. Jasbir Singh Kalra (Person under Promoter Group) under Reg 30 & Reg 31A (6)(c) of SEBI LODR Regulations 2015
Thu, 18 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyZenlabs Ethica Ltd
2CIN NO.L74900CH1993PLC033112
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Akshay Saxena
Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER
EmailId: secretarial@zenlabsethica.com
Name of the Chief Financial Officer: Adarsh Sharma
Designation: CHIEF FINANCIAL OFFICER
EmailId: zenlabsethicaltd2019@gmail.com

Date: 18/04/2024

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Mon, 15 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Zenlabs Ethica Ltd
2 CIN NO. L74900CH1993PLC033112
3 Report filed for FY 2023-2024
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 2023-24 2024-25
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)2022-23 2023-24
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-AKSHAY SAXENA
Designation :-COMPANY SECRETARY
Name of the Chief Financial Officer :- ADARSH SHARMA
Designation : -CHIEF FINANCIAL OFFICER

Date: 15/04/2024

Zenlabs Ethica Ltd. Technical Scans

View details >>
Wed, 24 Apr 2024
Opening at High Opening at High
Opening at High for 2 Days Opening at High for 2 Days
High Decrease in 3 Months High Decrease in 3 Months
MFI Crossed 20 From Above MFI Crossed 20 From Above
MFI Below 20 MFI Below 20

Zenlabs Ethica Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 346,885.24 3,038.10 -0.2%
Redington Ltd. 17,230.31 227.40 +3.1%
Honasa Consumer Ltd. 13,841.98 425.85 -0.4%
MMTC Ltd. 11,307.00 75.90 +0.7%
Entero Healthcare Solutions Ltd. 5,245.35 1,176.30 -2.6%
Lloyds Enterprises Ltd. 4,592.38 37.90 +5.0%
Veritas (India) Ltd. 3,937.99 1,498.20 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-12 98.75 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-12 14.32 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 425.85 -0.4%
MMTC Ltd. Consolidated 2023-12 85.49 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-12 36.15 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-12 20.55 1,498.20 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-12 8.99 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-12 2.38 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 21.02 425.85 -0.4%
MMTC Ltd. Consolidated 2023-12 7.69 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 3.35 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-12 3.03 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-12 1.59 1,498.20 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 1.16 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-03 0.45 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.01 425.85 -0.4%
MMTC Ltd. Consolidated 2023-03 0.14 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.63 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-03 0.06 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 0.10 1,498.20 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-03 22.66 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 425.85 -0.4%
MMTC Ltd. Consolidated 2023-03 247.70 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 4.30 1,498.20 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-03 22.66 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 425.85 -0.4%
MMTC Ltd. Consolidated 2023-03 247.70 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 4.30 1,498.20 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 136,977.76 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-03 79,376.78 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 1,492.75 425.85 -0.4%
MMTC Ltd. Consolidated 2023-03 3,528.18 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 3,300.21 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-03 380.30 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 2,163.22 1,498.20 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 2,208.94 3,038.10 -0.2%
Redington Ltd. Consolidated 2023-03 1,439.39 227.40 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 -150.97 425.85 -0.4%
MMTC Ltd. Consolidated 2023-03 1,562.27 75.90 +0.7%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 -11.10 1,176.30 -2.6%
Lloyds Enterprises Ltd. Consolidated 2023-03 45.03 37.90 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 94.81 1,498.20 +2.0%

Zenlabs Ethica Ltd. FAQ's

What is Zenlabs Ethica share price?
Can I buy Zenlabs Ethica shares now?
What is the Dividend Yield of Zenlabs Ethica?
What is the Market Cap of Zenlabs Ethica?
What are the key metrics to analyse Zenlabs Ethica?
What is the 52 Week High and Low of Zenlabs Ethica?